FGD3 and cancer: Since we and others have found that compounds based on the ErSO chemical scaffold do not induce TRPM4 dependent cell swelling and lytic cell death in mouse cancer cells [46], we could not assess the effect of FGD3 on immunogenicity in syngeneic mouse models.